Related Experiment Video

Updated: Jul 8, 2026

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

Genetics and epigenetics of renal cell cancer

Marcella M L Baldewijns1, Iris J H van Vlodrop, Leo J Schouten

  • 1Department of Pathology, GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.

Biochimica Et Biophysica Acta
|January 12, 2008
PubMed

Insights

Renal cell carcinoma (RCC) is a complex group of kidney cancers. Understanding its genetics and epigenetics is crucial for developing new diagnostic and therapeutic strategies.

Area of Science:

  • Oncology
  • Genetics
  • Epigenetics

Background:

  • Renal cell carcinoma (RCC) is not a single entity but a heterogeneous group of kidney tumors.
  • Current treatments for RCC are effective only in a subset of patients, and cure rates are stage-dependent.
  • Early detection and novel therapeutic approaches are essential due to limited treatment responses.

Purpose of the Study:

  • To review the background of renal cell carcinoma.
  • To discuss the clinical applications of genetics in RCC.
  • To explore the role of epigenetics in RCC diagnosis and treatment.

Main Methods:

  • Literature review of genetic and epigenetic alterations in renal cell carcinoma.
  • Analysis of current and developing therapeutic agents targeting RCC pathways.
  • Discussion of diagnostic and prognostic markers.

Main Results:

  • Genetic alterations are key drivers of renal cell cancer carcinogenesis.
  • Targeted therapies, particularly those inhibiting angiogenesis, show promise and are becoming standard care.
  • Epigenetic modifications are increasingly recognized for their role in tumorigenesis.

Conclusions:

  • Advances in understanding RCC genetics and epigenetics are paving the way for improved diagnostics and therapeutics.
  • Epigenetics holds significant potential for developing novel prognostic and early diagnostic markers for RCC.
  • Integrating genetic and epigenetic insights is vital for future RCC management.

More Related Videos

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy

Published on: April 29, 2014

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...